Arylia
Efectiveness of denosumab for fracture prevention in real‑world postmenopausal women with osteoporosis: a retrospective cohort study
Comparison of the efficacy between sequential therapy with teriparatide and denosumab and denosumab monotherapy in suppressing fragility fracture risk
Efcacy of denosumab on bisphosphonate‑treated osteoporosis and osteopenia in systemic rheumatic disease patients receiving glucocorticoids
Refracture risk and all-cause mortality after vertebral fragility fractures: Anti-osteoporotic medications matter
Real-life short-term effectiveness of anti-osteoporotic treatments: a longitudinal cohort study
Denosumab vs alendronate postmenopausal women
Arylia Monograph